HR8324

1) What happened: On April 16, 2026, Rep. Burlison (R-MO) introduced HR8324, the Great American Healthcare Plan. The bill was referred to seven committees (Energy & Commerce, Ways & Means, Education & Workforce, Judiciary, Armed Services, Veterans' Affairs, Foreign Affairs) — an unusually broad referral indicating jurisdictional complexity. As of May 18, 2026, the bill remains in committee with no further action. It is an early-stage bill with low near-term passage probability. 2) The money trail: HR8324 authorizes zero direct spending. It is a tax and regulatory reform bill, not an appropriations bill. The primary mechanism is amending the Internal Revenue Code (IRC §223) to increase HSA contribution limits and expand eligible expenses to include health insurance premiums, direct primary care, healthy food, vitamins, dietary supplements, sports/fitness expenses, and health care sharing ministry payments. It also allows HSA rollovers to children/parents, charitable contributions to HSAs, and rollovers from FSAs/HRAs. These changes reduce federal tax revenue (by allowing more pre-tax HSA contributions) but do not allocate funds to any entity. 3) Structural winners and losers: Winners include HSA administrators (banks, credit unions, financial firms like Optum Bank/UNH), retail pharmacies (CVS/CVS Health) that sell newly eligible items, and health insurers with strong HDHP product lines (HUM, ANTM). Losers include insurers with heavy traditional plan exposure (CNC's commercial segment is small; UNH's UnitedHealthcare faces premium erosion but Optum offsets). The hospital price transparency provisions (Title III) are separate but impose compliance costs on hospitals and insurers — no specific tickers are directly named. 4) Competitive landscape: The bill's HSA expansion favors insurers with established HDHP/HSA products (HUM, ANTM) over those focused on Medicaid/Medicare (CNC). CVS Health benefits uniquely from retail pharmacy sales of newly eligible items. UNH is a mixed bag: premium erosion at UnitedHealthcare vs. fee growth at Optum Bank. No real market data is provided for price trends. 5) Timeline: The bill is at the earliest legislative stage. It must pass through seven committees (each with jurisdiction over different provisions), then the House floor, then the Senate, then be signed by the President. Given the 119th Congress (2025-2027) is in its second session, the window for passage is narrow. The bill's broad referral and lack of Senate companion suggest low momentum. Passage probability is below 10% in the current Congress.